| GlaxoSmithKline AG - Infanrix hexa, Pulver und Suspension zur Herstellung einer Injektionssuspension | | 00640 | | 01 | | Infanrix hexa | | Pulver und Suspension zur Herstellung einer Injektionssuspension | | J07CA09 | | Diphtherie-Tetanus-Pertussis-Poliomyelitis-Haemophilus-influenzae-B-Hepatitis-B | | 02.10.2000 | | |
| | Composition | | I) DTPa-HepB-IPV: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.2 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80.
II) Hib: polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, lactosum, aluminium 0.12 mg ut aluminii phosphas, pro praeparatione.
I) et II) corresp. DTPa-HepB-IPV + Hib: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.32 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, lactosum, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80. | | Packungsbestandteile | | II | | | Suspension injectable | | | | | | | | | BAG: Principe actif | Concentr. |
|---|
| | 25 mcg | | | 10 mcg | | | 8 mcg | | | 30 UI | | | 25 mcg | | | 40 UI | | | 10 mcg | | | 40 UI | | | 8 UI | | | 32 UI |
| | | | Agents auxilliaires | Concentr. |
|---|
| | | | | 10 µg | | | | | | 20752 |
| |
| I | | | Suspension injectable | | | | | | | | Principe actif | Concentr. |
|---|
| | 25µg / 0.5ml | | | 10µg / 0.5ml | | | 8µg / 0.5ml | | | 30U.I. / 0.5ml | | | 25µg / 0.5ml | | | 40U.I. / 0.5ml | | | 40U.I. / 0.5ml | | | 8U.I. / 0.5ml | | | 32U.I. / 0.5ml |
| | BAG: Principe actif | Concentr. |
|---|
| | 25 mcg | | | 10 mcg | | | 8 mcg | | | 30 UI | | | 25 mcg | | | 40 UI | | | 10 mcg | | | 40 UI | | | 8 UI | | | 32 UI |
| | | | Agents auxilliaires | Concentr. |
|---|
| | | | | | | | 199 | | Sodium Chlorure | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | | 51.66 | 72.60 | B | LS | Non | | 004 | 10 x 1 | DDP | DDP | B | | Non |
|
|
